barr 874 4
Pill imprint barr 874 4 has been identified as Warfarin sodium 4 mg.
Warfarin is used in the treatment of heart failure; prevention of thromboembolism in atrial fibrillation; heart attack; deep vein thrombosis, first event; thromboembolic stroke prophylaxis (and more), and belongs to the drug class coumarins and indandiones. Not for use in pregnancy.
Warfarin 4 mg is not subject to the Controlled Substances Act.
See also related documents.
Warfarin sodium Images
- Imprint:
-
barr
874 4 - Strength:
- 4 mg
- Color:
- Blue
- Size:
- 11.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
hypromellose
magnesium stearate
corn starch
FD&C Blue No. 1
- Drug Class:
- Coumarins and indandiones
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0874
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4402 | Physicians Total Care Inc (repackager) |
| 43063-0218 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Warfarin Sodium resources
- Warfarin
- Warfarin (Wolters Kluwer)
- Warfarin Tablets (Wolters Kluwer)
- warfarin (Cerner Multum)
- warfarin (Micromedex) - Includes Dosage Information
- warfarin Intravenous (Micromedex) - Includes Dosage Information
- Warfarin Sodium (AHFS DI)
- Coumadin Injection (FDA)
- Warfarin (FDA)
- Warfarin Sodium (Wolters Kluwer)
Warfarin Sodium is associated with the treatment of:
- Antiphospholipid Syndrome
- Chronic Central Venous Catheterization
- Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery
- Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery
- Deep Vein Thrombosis, First Event
- Deep Vein Thrombosis, Recurrent Event
- Heart Attack
- Heart Failure
- Prevention of Thromboembolism in Atrial Fibrillation
- Prosthetic Heart Valves
- Prosthetic Heart Valves, Mechanical Valves
- Prosthetic Heart Valves, Tissue Valves
- Protein S Deficiency
- Pulmonary Embolism, First Event
- Pulmonary Embolism, Recurrent Event
- Thromboembolic Stroke Prophylaxis
Search Again
